UK Phage Therapy announces a collaboration with CPI, Fixed Phage, and the University of Leicester to establish Phage therapy infrastructure in the UK.
BioChimPharm, a Georgian biopharmaceutical company, announces the completion of the modernization and renovation of its historic phage manufacturing facility, which was originally built in 1934.
Fixed Phage secures further £1.5m investment to scale programmes in Animal & Veterinary Health and Human Health.
MicroMir shares results for the efficiency of oral and inhalation bacteriophage cocktails in their Post-Covid phage therapy rehabilitation study.
Phage-UK is now live. It is a network for clinicians and phage researchers that work together to help build a path for phage therapy to be accessible to patient based in the United Kingdom.
Creative Biolabs provides an overview of a study that looks into the possibility of bacteriophages monitoring their hosts.
Creative Biolabs shares insights on bacteriophage therapy to treat acne caused by specific strains of Cutibacterium acnes.
Creative Biolabs shares an outlook on the use of bacteriophages as a Tuberculosis diagnostic tool for the detection of TB infection.
Developments surrounding phage therapy in Australia have been approved to regulate the process of phage therapy, rather than a specific phage product.